Cell Pouch System™
Sernova’s Cell Pouch System™ is a novel implantable and scalable medical device which forms a natural environment in the body for the housing and long-term survival and function of therapeutic cells. These therapeutic cells release necessary proteins or hormones missing from the body to treat chronic diseases as an alternative to daily administration of drugs.
Sernova is a clinical-stage company developing products for the treatment of chronic diseases using therapeutic cells transplanted into an implanted medical device to replace missing proteins or hormones.
Sernova’s device forms a natural environment promoting the long-term function of therapeutic cells. The company’s first therapeutic indication is for the treatment of insulin-dependent diabetes.
The Cell Pouch System™ is a versatile product for the treatment of numerous chronic diseases. Sernova’s technology provides a natural, safe and effective environment for numerous protein and/or hormonal cell therapies.
Sernova is conducting a Phase I/II clinical study in subjects with diabetes; measures of safety and efficacy are the primary and secondary endpoints.
Watch a short video about us.
Watch Dr Philip Toleikis, Ph.D. on CTV News - June 7, 2018
Watch Dr Philip Toleikis, Ph.D. on Cell & Gene Investor Day - April 17, 2018
Sernova Retains FronTier Flex for Canadian Investor Relations and Marketing / November 09, 2018
Sernova Completes Oversubscribed Private Placement of $2,754,000 / July 23, 2018All Press Releases →
All Updates →